BC
Boxer Capital’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,287,782
| Closed | -$43.7M | – | 85 |
|
|
2021
Q3 | $43.7M | Hold |
2,287,782
| – | – | 1.53% | 16 |
|
|
2021
Q2 | $39.3M | Hold |
2,287,782
| – | – | 1.39% | 21 |
|
|
2021
Q1 | $51.2M | Hold |
2,287,782
| – | – | 1.73% | 13 |
|
|
2020
Q4 | $50.9M | Hold |
2,287,782
| – | – | 1.64% | 17 |
|
|
2020
Q3 | $33.8M | Hold |
2,287,782
| – | – | 1.17% | 20 |
|
|
2020
Q2 | $33.9M | Buy |
2,287,782
+1,562,000
| +215% | +$23.1M | 1.49% | 21 |
|
|
2020
Q1 | $7.96M | Buy |
725,782
+475,782
| +190% | +$5.22M | 0.54% | 41 |
|
|
2019
Q4 | $2.2M | Sell |
250,000
-150,000
| -38% | -$1.32M | 0.12% | 49 |
|
|
2019
Q3 | $2.99M | Buy |
+400,000
| New | +$2.99M | 0.22% | 41 |
|
|
2018
Q4 | – | Sell |
-100,000
| Closed | -$808K | – | 26 |
|
|
2018
Q3 | $808K | Hold |
100,000
| – | – | 0.09% | 24 |
|
|
2018
Q2 | $702K | Hold |
100,000
| – | – | 0.08% | 26 |
|
|
2018
Q1 | $1.42M | Hold |
100,000
| – | – | 0.15% | 30 |
|
|
2017
Q4 | $876K | Hold |
100,000
| – | – | 0.16% | 25 |
|
|
2017
Q3 | $1.17M | Sell |
100,000
-134,220
| -57% | -$1.57M | 0.27% | 27 |
|
|
2017
Q2 | $3.27M | Hold |
234,220
| – | – | 0.78% | 18 |
|
|
2017
Q1 | $3.21M | Hold |
234,220
| – | – | 0.7% | 19 |
|
|
2016
Q4 | $1.68M | Hold |
234,220
| – | – | 0.65% | 17 |
|
|
2016
Q3 | $3.55M | Hold |
234,220
| – | – | 1.59% | 14 |
|
|
2016
Q2 | $2.31M | Hold |
234,220
| – | – | 2.05% | 14 |
|
|
2016
Q1 | $3.12M | Buy |
+234,220
| New | +$3.12M | 3.05% | 10 |
|